Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Life Science Companies are Litigation Targets for Unhappy Investors

13h biospace
Life science companies are popular targets for securities fraud litigation. That’s the gist of a new report released by the law firm Dechert LLP. (38-3)

OCUL / Ocular Therapeutix, Inc. / SVLSF IV, LLC - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)*     Ocular Therapeutix, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 67576A100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule

OCUL / Ocular Therapeutix, Inc. / SVLSF IV, LLC - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)*     Ocular Therapeutix, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 67576A100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule

OCUL / Ocular Therapeutix, Inc. / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-14 sec.gov
SCHEDULE 13G Amendment No. 0 OCULAR THERAPEUTIX INC COMMON STOCK Cusip #67576A100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #67576A100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 3,057,448 Item 8: 0 Item 9: 3,057,448 Item 11: 10.386% Item 12: HC Cusip #67576A100 Item 1: Reporting Person - Abigail P.

OCUL / Ocular Therapeutix, Inc. / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-14 sec.gov
SCHEDULE 13G Amendment No. 0 OCULAR THERAPEUTIX INC COMMON STOCK Cusip #67576A100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #67576A100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 0 Item 6: 0 Item 7: 3,057,448 Item 8: 0 Item 9: 3,057,448 Item 11: 10.386% Item 12: HC Cusip #67576A100 Item 1: Reporting Person - Abigail P.

OCUL / Ocular Therapeutix, Inc. / SUMMER ROAD LLC - SCHEDULE 13 G FOR SUMMER ROAD LLC (Passive Investment)

2018-02-08 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       SCHEDULE 13G   Under the Securities Exchange Act of 1934     OCULAR THERAPEUTIX, INC. (Name of Issuer)   Common Stock (Title of Class of Securities)   67576A100 (CUSIP Number)   January 29, 2018 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover

OCUL / Ocular Therapeutix, Inc. / SUMMER ROAD LLC - SCHEDULE 13 G FOR SUMMER ROAD LLC (Passive Investment)

2018-02-08 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       SCHEDULE 13G   Under the Securities Exchange Act of 1934     OCULAR THERAPEUTIX, INC. (Name of Issuer)   Common Stock (Title of Class of Securities)   67576A100 (CUSIP Number)   January 29, 2018 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover

OCUL / Ocular Therapeutix, Inc. / SUMMER ROAD LLC - SCHEDULE 13 G FOR SUMMER ROAD LLC (Passive Investment)

2018-02-07 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       SCHEDULE 13G   Under the Securities Exchange Act of 1934     OCULAR THERAPEUTIX, INC. (Name of Issuer)   Common Stock (Title of Class of Securities)   67576A100 (CUSIP Number)   January 29, 2018 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover

OCUL / Ocular Therapeutix, Inc. / SUMMER ROAD LLC - SCHEDULE 13 G FOR SUMMER ROAD LLC (Passive Investment)

2018-02-07 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       SCHEDULE 13G   Under the Securities Exchange Act of 1934     OCULAR THERAPEUTIX, INC. (Name of Issuer)   Common Stock (Title of Class of Securities)   67576A100 (CUSIP Number)   January 29, 2018 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *The remainder of this cover

OCUL / Ocular Therapeutix, Inc. / JENNISON ASSOCIATES LLC - 13G AMENDED ANNUAL FILING - OCUL (Passive Investment)

2018-02-06 sec.gov
Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* December 31, 2017 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) Name of Issuer: Ocular Therapeutix, Inc. Title of Class of Securities: Common Stock CUSIP Number: 67576A100 *The remainder of this cover page shall be

OCUL / Ocular Therapeutix, Inc. / JENNISON ASSOCIATES LLC - 13G AMENDED ANNUAL FILING - OCUL (Passive Investment)

2018-02-06 sec.gov
Securities and Exchange Commission Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* December 31, 2017 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) Name of Issuer: Ocular Therapeutix, Inc. Title of Class of Securities: Common Stock CUSIP Number: 67576A100 *The remainder of this cover page shall be

OCUL / Ocular Therapeutix, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-01-29 fintel.io
Ocular Therapeutix, Inc. (NASDAQ:OCUL) has 74 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,645,704 shares. Largest shareholders include Versant Venture Management, LLC, Prudential Financial Inc, Jennison Associates Llc, SV Life Sciences Advisers, LLC, BlackRock Inc., Wellington Management Group Llp, FMR LLC / Fidelity, Columbus Circle Investors, Vanguard Group Inc, and State Street Corp. (85-3)

OCUL / Ocular Therapeutix, Inc. / PRUDENTIAL FINANCIAL INC - 3G/A (Passive Investment)

2018-01-29 sec.gov
13G HTML File DOCUMENT TYPE SC 13G/A TEXT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment # 3 Name of Issuer: Ocular Therapeutix, Inc _____________________________________________________ Title of Class of Securities: Common Stock CUSIP Number: 67576A100 1) NAME AND I.R.S. IDENTIFICATION NO. OF REPORTING PERSON Prudential Financial, Inc.

OCUL / Ocular Therapeutix, Inc. / PRUDENTIAL FINANCIAL INC - 3G/A (Passive Investment)

2018-01-29 sec.gov
13G HTML File DOCUMENT TYPE SC 13G/A TEXT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment # 3 Name of Issuer: Ocular Therapeutix, Inc _____________________________________________________ Title of Class of Securities: Common Stock CUSIP Number: 67576A100 1) NAME AND I.R.S. IDENTIFICATION NO. OF REPORTING PERSON Prudential Financial, Inc.

OCUL / Ocular Therapeutix, Inc. 424B5 (Prospectus)

2018-01-25 sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-210777 PROSPECTUS SUPPLEMENT (TO PROSPECTUS DATED APRIL 28, 2016) 6,500,000 Shares Ocular Therapeutix, Inc.   Common Stock $5.00 per share • Ocular Therapeutix, Inc. is offering 6,500,000 shares of common stock. • The last reported sale price of our common stock on January 24, 2018, was $6.


OCUL : Ocular Therapeutix Stock Analysis and Research Report

Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its bioresorbable hydrogel-based drug product candidates are designed to provide extended delivery of therapeutic agents to the eye. Its lead product candidates are DEXTENZA (dexamethasone insert), for the treatment of post-surgical ocular inflammation and pain, allergic conjunctivitis and dry eye disease, and OTX-TP, for the treatment of glaucoma and ocular hypertension, which are extended-delivery, drug-eluting inserts that are placed into the canaliculus through a natural opening called the punctum located in the inner portion of the eyelid near the nose. Its intracanalicular inserts combine its hydrogel technology with U.S. Food and Drug Administration, or FDA, approved therapeutic agents with the goal of providing extended delivery of drug to the eye. Ocular also has...

Click for full article
CUSIP: 67576A100